SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001047469-17-001845
Filing Date
2017-03-21
Accepted
2017-03-21 16:33:54
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3 a2231400zf-3.htm F-3 133446
2 EX-5.1 a2231400zex-5_1.htm EX-5.1 14398
3 EX-23.2 a2231400zex-23_2.htm EX-23.2 5150
4 G714229.JPG g714229.jpg GRAPHIC 13749
5 G84422KGI001.JPG g84422kgi001.jpg GRAPHIC 3544
6 G84422LCI001.JPG g84422lci001.jpg GRAPHIC 1908
7 G84422LCI002.GIF g84422lci002.gif GRAPHIC 3065
  Complete submission text file 0001047469-17-001845.txt   185399
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 1 PLACE VILLE MARIE, SUITE 2500 MONTREAL A8 H3B 1R1 843-900-3211
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-216853 | Film No.: 17704553
SIC: 2834 Pharmaceutical Preparations